Biomay Patents / Applications
 |  |
|---|---|
| |
| Method for screening an expression cDNA clone bank for the detection of polynucleotides | EP 414 808 US 5,786,466 US 5,837,550 |
| Method of production of birch pollen allergen P14 | EP 495 064 US 5,648,242 |
| Recombinant timothy grass pollen allergen Phl p 2 | EP 643 769 JP 3657604 |
| Recombinant cladiosporum herbarum allergens | EP 714 441 JP 3758671 |
| Nucleic Acid sequence and Protein, and Polypeptides encoding Mannitol Dehydrogenases or parts thereof, and their preparation and use in diagnostics and therapy | WO 03/083098 |
| Recombinant major allergen of Artemisia vulgaris (mugwort) pollen Art v 1 | EP 1 068 323 US 6,984,726 |
| Allergen from mugwort pollen | EP 1 509 606 WO 03/102189 |
| Allergy vaccines containing hybrid polypeptides | EP 1 219 301 US 2002-173625 |
| Hypoallergenic allergy vaccines based on Phl p7 | EP 1 403 280 US 2006-216314 |
| Hypoallergenic polypeptides based on fish parvalbumin | EP 1 512 659 US 2006-0140969 |
| Allergen from house-dust mites | EP 1 612 219 US 2006-0002948 |
| Hypoallergenic variant of Parietaria judaica major allergens uses and compositions thereof | WO 2004/104047 |
| Reagent for diagnosis and therapy of latex allergy and method for the preparation of the same | WO 2006/005535 |
| Use of an antibody | WO 2007/134350 |
| Allergen derivative | WO 2007/124526 |
| House dust mite allergen | WO 2007/124524 |
| |
| Allergy vaccines and their preparation | EP 1 219 299 US 7,244,431 |
| Process for the preparation of hypoallergenic mosaic antigens | EP 1 440 979 WO 2004/065414 |
| Vaccine carrier | WO 2007/140505 |
| Protein allergen derivatives | WO 2006/058359 |
| Method for evaluating the allergen sensitivity of an individual | WO 2006/084299 |
| |
| Allergy vaccines | EP 1 219 300 US 2002-0187158 |
| Microparticles comprising carbohydrate beads covalently linked with allergen for use in immunotherapy and diagnostics | WO 03/089009 |
| Antigen presenting vesicles | WO 03/039594 |
| Antigen-containing microspheres for allergy therapy | WO 2005/000274 |
NEWS
Boehringer Ingelheim RCV and Biomay Cooperate in GMP Manufacturing of Plasmid DNA (February 1, 2010)
Boehringer Ingelheim RCV GmbH & Co KG, one of the global leaders in the production of biopha Read more >>
New Aliquot Sizes and Prices of Research-grade Recombinant Allergens (Jan 20, 2010)
Biomay wishes to inform its customers about a few changes in the distribution of its research-gr Read more >>
Meet Biomay at BIO-Europe 2009 in Vienna (Nov. 2–4, 2009)
At the BIO-Europe partnering conference this year in Vienna, Biomay will address participants in Read more >>